The Minister for Health, Wicklow TD, Simon Harris says he has been assured that there will be no delay in accessing the drug Spinraza, following a lengthy campaign by parents of those affected.
The HSE’s leadership team has approved access to the drug for children with type 1, 2 and 3 Spinal Muscular Atrophy on an exceptional and individualised basis.
Earlier this year, the HSE said the drug would cost about €600,000 in the first year to treat each of the 25 Irish children with the disease and €380,000 a year thereafter,.
Spinraza is now approved in 26 countries around Europe with just Estonia rejecting it.
Five Charged Following Protest At Site Earmarked For Asylum Seekers In Newtown
East Coast FM Host 13th Annual Coffee Morning To Raise Funds For Hospice And Cancer Services
Redeveloped Arboretum Garden And Retail Centre Opens In Kilquade
Extension Approved For Gaelscoil In Arklow
IFA Say Dog Attacks In Wicklow Are Getting Worse
